Clinical trial

Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery

NCT04689945

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Morphine Normalized identity: morphineView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Erector Spinae Block Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Control Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-02-01

PhaseN/A

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

MorphineDRUG · verified · RxNorm: morphine

Erector Spinae BlockPROCEDURE

ControlDRUG

Sponsors & collaborators

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospitallead sponsor

Mapped research locations

AnkaraTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04689945 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.